Effect of Preoperative Intervention With Folic Acid and Vitamin B12 on Postoperative Neurobehavioral Changes in Children

Comparison of preoperative folic acid and VitB12 intervention on postoperative delirium and long-term neurobehavioral changes in children under general anesthesia

Study Overview

Detailed Description

Folic acid, as a one-carbon unit transferase coenzyme, participates in the synthesis of purine and thymine, and is an important element of the nervous system. Vitamin B12 participates in methyl conversion and folate metabolism in the body, promoting the conversion of 5-methyltetrahydrofolate to tetrahydrofolate. It has been reported that the lack of serum folic acid and B12 is associated with an increased risk of cognitive impairment. The explanation mechanism of the relationship between folic acid deficiency and cognitive dysfunction may be that folic acid deficiency leads to impaired central nervous system methylation, resulting in insufficient methyl synthesis of myelin sheaths, neurotransmitters, membrane phospholipids and deoxyribonucleic acid. Our previous studies showed that preoperative folic acid supplementation can alleviate myelin damage and cognitive impairment in young rats caused by sevoflurane anesthesia. Therefore, this study further explored the preoperative folic acid and coenzyme B12 supplementation for children's delirium and long-term neurobehavioral changes after general anesthesia.

Study Type

Interventional

Enrollment (Anticipated)

360

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: lei zhang, Doctor
  • Phone Number: 0086-18717822662
  • Email: weiymzhl@126.com

Study Contact Backup

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200001
        • Recruiting
        • China
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 2 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. ASA grade is Ⅰ ~ Ⅱ;
  2. Children aged 6 months to 2 years old;
  3. It is planned to undergo head, neck and maxillofacial surgery under general anesthesia with anesthesia for less than 6 hours

Exclusion Criteria:

  1. Children with a history of respiratory tract infection within 1 week;
  2. Children with congenital malformations such as congenital heart disease;
  3. Children with central nervous system diseases or mental disorders or mental disorders;
  4. Children with long-term use of sedative or analgesic drugs;
  5. Children with severe liver and kidney dysfunction;
  6. Received folic acid and VitB12 supplement treatment or taken related derivatives;
  7. Have taken drugs that affect absorption within the past month, such as sulfonamides, aspirin, etc .;
  8. Those who have participated in other relevant clinical research in the past 3 months;
  9. Children with stunting

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Intervention group
Before the operation, the patient took 20ml of brown sugar aqueous solution containing folic acid and VitB12 for 3 days (folic acid concentration is 0.4mg / d for 2 year old children + 1.2μg / d of VitB12, dissolved in 20ml brown sugar water once a day). Postoperatively, PAED scores were performed at the time of awakening, extubation and every 10min within 30min after extubation. 10 points is defined as delirium during the recovery period). Long-term neurobehavioral changes were evaluated using the Gesell scale, followed up every six months until the age of three
Take folic acid and VitB12 for 3 consecutive days before surgery
PLACEBO_COMPARATOR: Placebo group
The patients in the placebo group took 20 ml of brown sugar aqueous solution with the same concentration as the intervention group 3 days before the operation. Postoperatively, PAED scores were performed at the time of recovery, extubation, and every 10 minutes within 30 minutes after extubation. The PAED scores of all children were measured by the same person. (The total score is 0-20, and the score ≥10 is defined as delirium during the recovery period). Long-term neurobehavioral changes were evaluated using the Gesell scale, followed up every six months until the age of three
take 20 ml of brown sugar aqueous solution with the same concentration as the intervention group 3 days before the operation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PAED scale
Time Frame: 10 minutes after surgery
Observe whether the index will cause delirium during the recovery period.The evaluation range of the PAED scale is 0-20 points, If the score exceeds 10 points, Then it is considered delirium.
10 minutes after surgery
Gesell scale
Time Frame: 2 day after surgery
Through the gesell scale, 5 tests are carried out on children: gross motor ability, fine movement, physical ability, verbal ability, and human ability.The evaluation range of the Gesell scale is 0-100 points. If the score is higher, it means good. If the score is low, it means that the result is not good. If the result is not good, it may be caused by anesthesia, so we conducted this evaluation.
2 day after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: During the induction period of anesthesia, intubation, and the operation period;immediately after entering the resuscitation room (T1), 5 minutes before extubation (T2), immediately after extubation (T3), and 2 minutes after extubation (T4);
Observe heart rate through a monitor
During the induction period of anesthesia, intubation, and the operation period;immediately after entering the resuscitation room (T1), 5 minutes before extubation (T2), immediately after extubation (T3), and 2 minutes after extubation (T4);
Mean Blood Pressure
Time Frame: During the induction period of anesthesia, intubation, and the operation period;immediately after entering the resuscitation room (T1), 5 minutes before extubation (T2), immediately after extubation (T3), and 2 minutes after extubation (T4);
Observe and calculated mean blood pressure through a monitor
During the induction period of anesthesia, intubation, and the operation period;immediately after entering the resuscitation room (T1), 5 minutes before extubation (T2), immediately after extubation (T3), and 2 minutes after extubation (T4);
Extubation time
Time Frame: immediately after surgery
Extubation time
immediately after surgery
Ramsay sedation score
Time Frame: 10 minutes after extubation
Ramsay sedation score after recovery, extubation and every 10min within 30min after extubation,Ramsay sedation score is 1-6 points. If the score is 2-4 points,That result is satisfactory, 5-6 points are excessive sedation.
10 minutes after extubation
Postoperative pain CHEOPs scores
Time Frame: 20 minutes after extubation

The postoperative pain CHEOPs scores were taken at the time of extubation and every 10 minutes within 30 minutes after extubation (the total score was less than 6 points, there was no pain, and ≥10 points for corresponding analgesia treatment).

The total score is 46 points, if the total score is less than 6 points, it is judged as no pain

20 minutes after extubation
Narcotic drugs
Time Frame: During the surgery
The use of narcotic drugs (eg pentazocine, propofol)
During the surgery
Other adverse events during the recovery period
Time Frame: Immediately after the surgery
Other adverse events during the recovery period (eg nausea and vomiting, bronchospasm, respiratory depression, etc.)
Immediately after the surgery
recovery time
Time Frame: immediately after recovery
recovery time
immediately after recovery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: hong jiang, Doctor, Director of Anesthesiology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2020

Primary Completion (ANTICIPATED)

June 30, 2025

Study Completion (ANTICIPATED)

June 30, 2025

Study Registration Dates

First Submitted

June 14, 2020

First Submitted That Met QC Criteria

June 29, 2020

First Posted (ACTUAL)

July 7, 2020

Study Record Updates

Last Update Posted (ACTUAL)

July 7, 2020

Last Update Submitted That Met QC Criteria

June 29, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on Folic acid and vitamin B12

Subscribe